Translational Research

The Vancouver Prostate Centre is heavily focused on translational research, which is the ability to move laboratory discoveries through the checks and balances into clinical trials, and eventually to develop these research findings into new and more effective treatments.

PC-TRiADD is the Vancouver Prostate Centre’s Translational Research Initiative for Accelerated Discovery and Development.

This initiative dives down to the molecular level to understand prostate cancer progression and treatment resistance and uses that information to develop new services and products to improve cancer outcomes.

Previously funded by the Government of Canada as a Centre of Excellence for Commercialization and Research (CECR), PC-TRiADD also offers pharmaceutical and biotech companies, as well as external researchers, integrated translational research services such as drug discovery, preclinical testing, tumour biology and clinical research.

The UBC Faculty of Medicine posted a profile of the translational research breakthroughs being made at our Centre. "Translating research to treat prostate cancer" features our Executive Director Dr. Gleave and discusses the innovative potential therapeutics discovered by Drs. Rennie, Cherkasov and Zoubeidi.

 

Updated October 20, 2020

 

Research2Reality interview with Dr. Gleave

Dr. Gleave discusses the role of research in the development of new drug combinations and personalized treatments for prostate cancer on Research2Reality's Orange Chair Sessions (2.5 minutes).

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Conference Flyer Page 1

Breast & Prostate Cancer half-day virtual conference: Saturday, September 18th, 2021

The What you Need to Know for Your Patients Post Breast & Prostate Cancer Conference, taking place online on Saturday, September 18th, 2021 from 8:00am – 1:30pm, is an accredited virtual half-day conference focusing on screening, treatment, side-effect management & emerging new therapies for breast & prostate cancer patients. Click here for more information and to register. 

Dr. Peter Black, team captain

Terry Fox Run fundraiser: September 19th, 2021

The 41st Annual Terry Fox Run is taking place on Sunday September 19, 2021. If you are able, please consider donating to our team (tax receipts issued), raising funds for the Terry Fox Foundation's ground-breaking cancer research. 

Employment

Work at the Vancouver Prostate Centre

Wednesday, September 8, 2021

Recent publication proposes a potential new therapeutic approach to treatment-resistant prostate cancer

Tuesday, August 3, 2021

Dr. Cherkasov receives 2021 Faculty of Medicine Distinguished Achievement Award

Dr. Cherkasov